Status:
COMPLETED
Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.
Lead Sponsor:
Nicolaus Copernicus University
Conditions:
Neoplasms
Antioxidants
Eligibility:
All Genders
18+ years
Brief Summary
The research aims to determine the parameters of oxidative stress and inflammatory processes and compare these parameters with the image obtained using positron emission tomography (PET) with 2-deoxy-...
Detailed Description
FDG PET/CT is very sensitive imaging tool for the detection of neoplasms. Neoplasm tissue is characterized by a much higher level of metabolism than healthy tissues, therefore a 95% cases of use the m...
Eligibility Criteria
Inclusion
- \- sign informed consent form for participation in the study
Exclusion
- other diseases,
- bad feeling of the studied individual on the day of the study,
- the participants will not be minor and incapacitated persons, soldiers, prisoners and persons dependent in any way from the investigators.
Key Trial Info
Start Date :
June 19 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT03470857
Start Date
June 19 2017
End Date
June 30 2021
Last Update
September 28 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chair of Medical Biology, Collegium Medicum of Nicolaus Copernicus University
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-092
2
Department of Nuclear Medicine of Center Oncology in Bydgoszcz
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-796
3
Department of Positron Emission Tomography and Molecular Diagnostics, Collegium Medicum of Nicolaus Copernicus University
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-796